Change in Serum Levels of NT-proBNP During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
Observational prospective study to evaluate serum NT-proBNP levels in a population of COPD patients three months after the iniation of triple inhaled formoterol/glycopyrrolate/budesonide therapy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:
• COPD;
• Clinical indication for triple inhalation therapy with formoterol/glycopyrrolate/budesonide;
Locations
Other Locations
Italy
INRCA Hospital
RECRUITING
Ancona
IRCCS INRCA Hospital
RECRUITING
Osimo
Contact Information
Primary
Anna Rita Bonfigli
a.bonfigli@inrca.it
0718003719
Time Frame
Start Date: 2022-06-28
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 29
Related Therapeutic Areas
Sponsors
Leads: Istituto Nazionale di Ricovero e Cura per Anziani